Skip to main content
Premium Trial:

Request an Annual Quote

David Urdal, Mark Gabrielson, Stephen Blose, Klaas Kok

Premium
Gene Logic has added David Urdal and Mark Gabrielson to its board of directors, while Jules Blake has retired from the board, the company said last week.
 
Urdal is currently senior vice president and CSO at Dendreon. Previously he was president of Immunex.
 
Gabrielson is co-founder, director, and CEO of Pulmatrix, and has held posts at SmithKline Beecham and Prince Ventures.
 
Blake has been a board director at Gene Logic since 1994.
 

 
Stephen Blose has been elected to be chairman of BioMicro Systems, the company said last week. Blose has been a member of BioMicro’s board for three years.
 
Blose is CEO of Mill Valley Summit Group, which offers services and consulting for venture capital firms and life science companies.
 
Blose also has been a division general manager at Bio-Rad, working on commercializing DNA, informatics, and other systems. Before that he was president and CEO of Protein Databases.
 

 
Agilent Technologies announced last week that Klaas Kok has won 50 free microarrays in its microarray contest on the basis of his research. Kok is a professor in the department of genetics at the University Medical Center Groningen in the Netherlands.
 
Kok’s contest entry combined array-based comparative genomic hybridization with traditional gene-expression profiling in the search for novel tumor suppressor genes implicated in conventional renal cell carcinoma. Nearly 100 teams entered the contest, which ran from November 2006 through January 2007, Agilent said.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.